Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE47.4700
- TODAY'S CHANGE (%)-1.1600 (-2.3854%)
- Bid / Lots46.8300/ 1
- Ask / Lots49.9800/ 1
- Open / Previous Close48.9400 / 48.6300
- Day Range
- 52 Week Range
- Volume550,435
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 4498 | 48.89 |
| 09:34 ET | 1200 | 48.56 |
| 09:36 ET | 100 | 48.56 |
| 09:38 ET | 1766 | 49.09 |
| 09:41 ET | 100 | 49.19 |
| 09:43 ET | 1867 | 49.3038 |
| 09:45 ET | 1868 | 49.26 |
| 09:50 ET | 1100 | 49.17 |
| 09:56 ET | 1006 | 49.2073 |
| 09:57 ET | 460 | 49.13 |
| 09:59 ET | 237 | 49.21 |
| 10:01 ET | 1579 | 49.37 |
| 10:03 ET | 300 | 49.39 |
| 10:06 ET | 2500 | 49.33 |
| 10:08 ET | 4992 | 49.1 |
| 10:12 ET | 100 | 49.11 |
| 10:14 ET | 1861 | 49.0875 |
| 10:15 ET | 100 | 49.115 |
| 10:17 ET | 300 | 49.1075 |
| 10:19 ET | 1787 | 49.06 |
| 10:21 ET | 700 | 49.05 |
| 10:26 ET | 1200 | 48.97 |
| 10:28 ET | 400 | 48.89 |
| 10:30 ET | 300 | 48.97 |
| 10:33 ET | 103 | 49.0399 |
| 10:35 ET | 4488 | 49.04 |
| 10:37 ET | 1404 | 49.13 |
| 10:39 ET | 1200 | 49.06 |
| 10:42 ET | 500 | 49.04 |
| 10:44 ET | 100 | 49.0325 |
| 10:46 ET | 100 | 49.045 |
| 10:48 ET | 715 | 49.0744 |
| 10:50 ET | 200 | 49.08 |
| 10:51 ET | 1057 | 49.085 |
| 10:53 ET | 392 | 49.06 |
| 10:55 ET | 600 | 49.1101 |
| 10:57 ET | 2188 | 49.06 |
| 11:00 ET | 100 | 49.1061 |
| 11:02 ET | 1400 | 49.055 |
| 11:04 ET | 536 | 49.09 |
| 11:06 ET | 200 | 49.04 |
| 11:08 ET | 493 | 49.08 |
| 11:09 ET | 200 | 49.05 |
| 11:11 ET | 2000 | 49.07 |
| 11:13 ET | 300 | 49.075 |
| 11:18 ET | 1042 | 49.01 |
| 11:20 ET | 200 | 49 |
| 11:22 ET | 900 | 48.99 |
| 11:26 ET | 529 | 48.97 |
| 11:27 ET | 200 | 48.97 |
| 11:29 ET | 100 | 48.99 |
| 11:31 ET | 2734 | 49 |
| 11:33 ET | 2433 | 49.06 |
| 11:36 ET | 2670 | 48.955 |
| 11:38 ET | 792 | 48.78 |
| 11:40 ET | 900 | 48.7 |
| 11:42 ET | 200 | 48.64 |
| 11:44 ET | 1255 | 48.605 |
| 11:45 ET | 500 | 48.58 |
| 11:49 ET | 432 | 48.58 |
| 11:51 ET | 1450 | 48.49 |
| 11:54 ET | 1230 | 48.54 |
| 11:56 ET | 100 | 48.54 |
| 11:58 ET | 400 | 48.56 |
| 12:00 ET | 1093 | 48.55 |
| 12:02 ET | 401 | 48.68 |
| 12:03 ET | 1094 | 48.6 |
| 12:05 ET | 100 | 48.64 |
| 12:07 ET | 100 | 48.65 |
| 12:09 ET | 1630 | 48.605 |
| 12:12 ET | 1000 | 48.61 |
| 12:14 ET | 1632 | 48.8 |
| 12:16 ET | 1820 | 48.815 |
| 12:18 ET | 358 | 48.89 |
| 12:20 ET | 400 | 48.885 |
| 12:21 ET | 500 | 48.895 |
| 12:23 ET | 300 | 48.885 |
| 12:25 ET | 890 | 48.94 |
| 12:27 ET | 100 | 48.98 |
| 12:30 ET | 1736 | 48.965 |
| 12:32 ET | 300 | 49.03 |
| 12:34 ET | 2400 | 48.995 |
| 12:36 ET | 200 | 48.995 |
| 12:38 ET | 20498 | 48.87 |
| 12:39 ET | 393 | 48.935 |
| 12:43 ET | 1505 | 48.95 |
| 12:45 ET | 1384 | 48.83 |
| 12:50 ET | 395 | 48.75 |
| 12:52 ET | 200 | 48.7 |
| 12:54 ET | 100 | 48.67 |
| 12:56 ET | 574 | 48.705 |
| 12:57 ET | 2601 | 48.57 |
| 12:59 ET | 2100 | 48.47 |
| 01:01 ET | 1034 | 48.4 |
| 01:03 ET | 100 | 48.34 |
| 01:06 ET | 300 | 48.3 |
| 01:08 ET | 800 | 48.345 |
| 01:10 ET | 100 | 48.31 |
| 01:12 ET | 600 | 48.31 |
| 01:15 ET | 3000 | 48.43 |
| 01:17 ET | 450 | 48.4125 |
| 01:19 ET | 5595 | 48.47 |
| 01:21 ET | 1400 | 48.52 |
| 01:24 ET | 400 | 48.515 |
| 01:26 ET | 200 | 48.515 |
| 01:28 ET | 864 | 48.515 |
| 01:30 ET | 100 | 48.54 |
| 01:32 ET | 558 | 48.49 |
| 01:33 ET | 1400 | 48.34 |
| 01:35 ET | 2228 | 48.46 |
| 01:37 ET | 200 | 48.49 |
| 01:39 ET | 100 | 48.48 |
| 01:42 ET | 100 | 48.455 |
| 01:44 ET | 3513 | 48.39 |
| 01:46 ET | 1200 | 48.31 |
| 01:48 ET | 100 | 48.26 |
| 01:50 ET | 400 | 48.255 |
| 01:51 ET | 450 | 48.3 |
| 01:53 ET | 900 | 48.295 |
| 01:55 ET | 1236 | 48.13 |
| 01:57 ET | 500 | 48.23 |
| 02:00 ET | 723 | 48.21 |
| 02:02 ET | 600 | 48.195 |
| 02:04 ET | 1603 | 48.18 |
| 02:06 ET | 200 | 48.175 |
| 02:08 ET | 100 | 48.15 |
| 02:09 ET | 7741 | 48.06 |
| 02:11 ET | 100 | 48.03 |
| 02:13 ET | 1289 | 48.04 |
| 02:15 ET | 8674 | 48.055 |
| 02:18 ET | 300 | 48.045 |
| 02:20 ET | 4934 | 47.995 |
| 02:22 ET | 5131 | 48.02 |
| 02:24 ET | 739 | 48 |
| 02:26 ET | 563 | 48.11 |
| 02:27 ET | 200 | 48.14 |
| 02:29 ET | 1191 | 48.04 |
| 02:31 ET | 300 | 48.01 |
| 02:33 ET | 2900 | 47.95 |
| 02:36 ET | 400 | 47.92 |
| 02:38 ET | 600 | 47.91 |
| 02:40 ET | 100 | 47.86 |
| 02:42 ET | 428 | 47.855 |
| 02:44 ET | 1500 | 47.8544 |
| 02:45 ET | 400 | 47.8625 |
| 02:47 ET | 2509 | 47.945 |
| 02:49 ET | 100 | 47.945 |
| 02:51 ET | 800 | 47.92 |
| 02:54 ET | 1100 | 47.86 |
| 02:56 ET | 3400 | 47.84 |
| 02:58 ET | 100 | 47.88 |
| 03:00 ET | 300 | 47.83 |
| 03:02 ET | 3623 | 47.955 |
| 03:03 ET | 1700 | 47.93 |
| 03:07 ET | 300 | 47.885 |
| 03:09 ET | 100 | 47.87 |
| 03:14 ET | 3477 | 47.685 |
| 03:16 ET | 800 | 47.54 |
| 03:18 ET | 2053 | 47.71 |
| 03:20 ET | 400 | 47.72 |
| 03:21 ET | 1368 | 47.73 |
| 03:23 ET | 3582 | 47.74 |
| 03:25 ET | 625 | 47.84 |
| 03:27 ET | 700 | 47.74 |
| 03:30 ET | 1146 | 47.705 |
| 03:32 ET | 1926 | 47.8 |
| 03:34 ET | 1504 | 47.69 |
| 03:36 ET | 1100 | 47.59 |
| 03:38 ET | 200 | 47.56 |
| 03:39 ET | 2601 | 47.755 |
| 03:41 ET | 4934 | 47.64 |
| 03:43 ET | 500 | 47.59 |
| 03:45 ET | 1400 | 47.53 |
| 03:48 ET | 2418 | 47.512 |
| 03:50 ET | 5074 | 47.57 |
| 03:52 ET | 10553 | 47.7 |
| 03:54 ET | 3362 | 47.725 |
| 03:56 ET | 14787 | 47.5 |
| 03:57 ET | 9682 | 47.51 |
| 03:59 ET | 16961 | 47.47 |
May 23, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Outperform by Baird, from 12:48PM ET on Thursday May 23, 2024 by Dow Jones
12:48PM ET on Thursday May 23, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Is Maintained at Overweight by Morgan Stanley, from 11:33AM ET on Thursday May 23, 2024 by Dow Jones
11:33AM ET on Thursday May 23, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 7:25AM ET on Thursday May 23, 2024 by Dow Jones
7:25AM ET on Thursday May 23, 2024 by Dow Jones
May 22, 2024
Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts, from 8:00AM ET on Wednesday May 22, 2024 by Dow Jones
8:00AM ET on Wednesday May 22, 2024 by Dow Jones
May 14, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 8:55AM ET on Tuesday May 14, 2024 by Dow Jones
8:55AM ET on Tuesday May 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.7B | -12.6x | --- |
Merus NV | 3.5B | -22.0x | --- |
Immunovant Inc | 4.2B | -15.9x | --- |
Biohaven Ltd | 3.2B | -5.4x | --- |
SpringWorks Therapeutics Inc | 3.1B | -8.2x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -12.6x |
Price/Sales (TTM) | 1,896.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
